[go: up one dir, main page]

AR134197A1 - Compuestos para el tratamiento de enfermedad renal - Google Patents

Compuestos para el tratamiento de enfermedad renal

Info

Publication number
AR134197A1
AR134197A1 ARP240102954A ARP240102954A AR134197A1 AR 134197 A1 AR134197 A1 AR 134197A1 AR P240102954 A ARP240102954 A AR P240102954A AR P240102954 A ARP240102954 A AR P240102954A AR 134197 A1 AR134197 A1 AR 134197A1
Authority
AR
Argentina
Prior art keywords
compounds
treatment
kidney disease
compound
atropisomer
Prior art date
Application number
ARP240102954A
Other languages
English (en)
Inventor
James Robert Austin
Dean Boyall
Ewa Iwona Chudyk
Dawid Deneka
James Dodd
Simon Robert Everitt
Belinda Rafaella Faust
Damien Jacques Michel Fraysse
Jeffery Allen Gladding
Hamish Bruce Hepburn
Shazia Keily
Ronald Marcellus Knegtel
Brad D Maxwell
James Jun Bon MUI
Chady Nasrallah
Joanne Louise Pinder
Alistair Peter Rutherford
Alan Alessandro Salman
Miranda Wright
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of AR134197A1 publication Critical patent/AR134197A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un compuesto de fórmula (1). Una composición farmacéutica que comprende un compuesto, tautómero, atropisómero, derivado deuterado, o sal o profármaco farmacéuticamente aceptable de acuerdo con una cualquiera de las reivindicaciones 1 a 31 y un portador farmacéutico.
ARP240102954A 2023-10-30 2024-10-30 Compuestos para el tratamiento de enfermedad renal AR134197A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202363594357P 2023-10-30 2023-10-30

Publications (1)

Publication Number Publication Date
AR134197A1 true AR134197A1 (es) 2025-12-10

Family

ID=93463014

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP240102954A AR134197A1 (es) 2023-10-30 2024-10-30 Compuestos para el tratamiento de enfermedad renal

Country Status (3)

Country Link
AR (1) AR134197A1 (es)
TW (1) TW202535871A (es)
WO (1) WO2025096453A1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104311555B (zh) * 2014-09-19 2016-04-20 广东东阳光药业有限公司 吡唑并哌啶酮类化合物及其组合物及用途
GB201905711D0 (en) * 2019-04-24 2019-06-05 Galapagos Nv Novel compounds and pharmaceutical compositions thereof for the treatment of kidney diseases

Also Published As

Publication number Publication date
TW202535871A (zh) 2025-09-16
WO2025096453A1 (en) 2025-05-08

Similar Documents

Publication Publication Date Title
CL2023000196A1 (es) Compuestos de tetrahidropirazolo-pirazinil-dihidroimidazolona o tetrahidropirazolo-piridinil-dihidroimidazolona y métodos de uso de los mismos
PH12022553378A1 (en) Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
CO2024001367A2 (es) Compuestos antivirales
AR132007A1 (es) Compuestos y métodos para modular ras-pi3k
AR118805A2 (es) Terapia de combinación para el tratamiento de la diabetes
AR126251A1 (es) Inhibidores de cdk2
ECSP23020167A (es) Inhibidores de apol1 y métodos para usar los mismos
CO2021014210A2 (es) Compuestos de pirrol
UY39799A (es) Compuestos de pirrolil–sulfonamida
CO2021017202A2 (es) Compuestos tricíclicos
MX2024011179A (es) Compuestos multiciclicos
AR127496A1 (es) Compuestos de cd73
AR134197A1 (es) Compuestos para el tratamiento de enfermedad renal
AR132818A1 (es) Compuestos para la degradación de la cinasa egfr
AR062545A1 (es) Formulaciones estables de quinolinonas
AR130303A1 (es) Compuestos de pirazolilsulfonamida y su uso terapéutico
AR129212A1 (es) Compuestos piridona como inhibidores de trpa1
AR129171A1 (es) Compuestos heteroaromáticos
AR057403A1 (es) 4- anilino-3-quinolincarbonitrilos para el tratamiento del cancer
AR125934A1 (es) Compuestos macrocíclicos para tratar enfermedades
AR133855A1 (es) Compuestos de amina sustituida, composiciones y métodos de uso
AR128894A1 (es) Inhibidores de kras
AR133755A1 (es) Compuestos de modulación de kras g12d
CR20240570A (es) Compuestos de cd73
AR133133A1 (es) Compuestos que modulan kras